Local Institution

Yekaterinburg 620144

0 studies enrolling now · 8 studies all time

What they study most

Acute Coronary Syndrome, Acute Coronary Syndromes, Atrial Fibrillation, Rheumatoid Arthritis, Rheumatoid Arthritis (RA), Squamous Cell Carcinoma of the Head and Neck, Systemic Lupus Erythematosus

Studies at this site

• Phase IIB Rheumatoid Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to Methotrexate — Completed
• Nivolumab or Nivolumab Plus Cisplatin, in Combination With Radiotherapy in Patients With Cisplatin-ineligible or Eligible Locally Advanced Squamous Cell Head and Neck Cancer — Completed
• Effects of Abatacept in Patients With Early Rheumatoid Arthritis — Completed
• A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart — Completed
• A Phase III Study of Apixaban in Patients With Atrial Fibrillation — Completed
• Phase III Acute Coronary Syndrome — Stopped early
• Methotrexate-Inadequate Response Study — Completed
• Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis — Stopped early